JACOBS LEVY EQUITY MANAGEMENT, INC

Position in CRBU — Caribou Biosciences, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in CRBU

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$723,323

+$41,336 QoQ

Shares Held

410,979

+14.5% QoQ

Ownership

0.383%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 137 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. CRBU ranks #62 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$723,323	410,979	+14.5%	Shares	Sole	2026-08-14
2026-03-31	$681,987	358,941	-56.5%	Shares	Sole	2026-05-15
2025-12-31	$1,310,635	824,299	+136.1%	Shares	Sole	2026-02-13
2025-09-30	$813,363	349,083	-63.5%	Shares	Sole	2025-11-17
2025-06-30	$1,205,794	956,980	-33.6%	Shares	Sole	2025-08-14
2025-03-31	$1,316,656	1,442,121	+19.4%	Shares	Sole	2025-05-15
2024-12-31	$1,920,829	1,208,069	+177.1%	Shares	Sole	2025-02-14
2023-06-30	$1,853,102	436,024	+1253.3%	Shares	Sole	2023-08-14
2023-03-31	$171,088	32,220	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.